PCS-2023: 3E0W Introduction, Lymphatics

PCS-2023 > 3 > 3E > 3E0 > 3E0W

3E0	Physiological Systems and Anatomical Regions, Introduction
	Info:	Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
3E0W	Introduction, Lymphatics
3E0W3	Percutaneous
3E0W30	Antineoplastic
3E0W305	Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach
3E0W30M	Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach
3E0W32	Anti-infective
3E0W328	Introduction of Oxazolidinones into Lymphatics, Percutaneous Approach
3E0W329	Introduction of Other Anti-infective into Lymphatics, Percutaneous Approach
3E0W33	Anti-inflammatory
3E0W33Z	Introduction of Anti-inflammatory into Lymphatics, Percutaneous Approach
3E0W36	Nutritional Substance
3E0W36Z	Introduction of Nutritional Substance into Lymphatics, Percutaneous Approach
3E0W37	Electrolytic and Water Balance Substance
3E0W37Z	Introduction of Electrolytic and Water Balance Substance into Lymphatics, Percutaneous Approach
3E0W3B	Anesthetic Agent
3E0W3BZ	Introduction of Anesthetic Agent into Lymphatics, Percutaneous Approach
3E0W3H	Radioactive Substance
3E0W3HZ	Introduction of Radioactive Substance into Lymphatics, Percutaneous Approach
3E0W3K	Other Diagnostic Substance
3E0W3KZ	Introduction of Other Diagnostic Substance into Lymphatics, Percutaneous Approach
3E0W3N	Analgesics, Hypnotics, Sedatives
3E0W3NZ	Introduction of Analgesics, Hypnotics, Sedatives into Lymphatics, Percutaneous Approach
3E0W3T	Destructive Agent
3E0W3TZ	Introduction of Destructive Agent into Lymphatics, Percutaneous Approach
3E0W3G	Other Therapeutic Substance
3E0W3GC	Introduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approach

and

Physiological Systems and Anatomical Regions, Introduction

Introduction, Lymphatics